Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function
Christopher L. Marsh(Scripps Health), M. Roy First(Eurofins (France)), Courtney Schieve, Daniel G. Maluf(University of Virginia), J.C. Rice(Scripps Institution of Oceanography), Anita Patel(University of Maryland, Baltimore), Didier A. Mandelbrot(UW Health University Hospital), John J. Friedewald(Northwestern University), J. David, Sunil M. Kurian(Scripps Clinic), D. Lee, Roslyn B. Mannon(University of Nebraska Medical Center), Michaël Abécassis(University of Arizona), Richard J. Knight(Methodist Hospital), Jamie Case(Scripps Clinic), V.R. Peddi(California Pacific Medical Center), Bethany Barrick(Scripps Clinic), Stanley Rose, Thomas Whisenant(University of California San Diego)
Cited by 39
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k